{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:33:53Z","timestamp":1790508833660,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.diagmicrobio.2006.04.006","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T10:21:22Z","timestamp":1152267682000},"page":"147-152","source":"Crossref","is-referenced-by-count":37,"title":["Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections"],"prefix":"10.1016","volume":"56","author":[{"given":"Michael A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna A.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib1","first-page":"721","article-title":"Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity","volume":"42","author":"Agut","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib2","first-page":"718","article-title":"Inhibition of ergosterol synthesis by sertaconazole in Candida albicans","volume":"42","author":"Agut","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib3","first-page":"767","article-title":"Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses","volume":"42","author":"Alomar","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jac\/36.4.713","article-title":"In-vitro antifungal activity of sertaconazole, econazole, and bifonazole against Candida spp.","volume":"36","author":"Carrillo-Mu\u00f1oz","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000239596","article-title":"Comparative study of antifungal activity of sertaconazole, terbinafine, and bifonazole against clinical isolates of Candida spp. Cryptococcus neoformans and dermatophytes","volume":"43","author":"Carrillo-Mu\u00f1oz","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000072449","article-title":"In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility","volume":"49","author":"Carrillo-Mu\u00f1oz","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000082631","article-title":"In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis","volume":"50","author":"Carrillo-Mu\u00f1oz","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/00325481.1992.11701210","article-title":"Superficial fungal infections. Topical and oral treatment of common types","volume":"91","author":"Cohn","year":"1992","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib9","article-title":"Comparison of the efficacy and tolerance of sertaconazole and sulconazole cream in patients suffering from cutaneous candidiasis and dermatophytosis: a double-blind, randomised, multicentric study","author":"Contet-Audonneau","year":"1994"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib10","article-title":"Sertaconazole nitrate rapidly achieves high concentrations in the stratum corneum with prolonged retention time","author":"Day","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0190-9622(96)80135-6","article-title":"Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines\/Outcomes Committee. American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib12","first-page":"705","article-title":"In vitro antifungal activity of sertaconazole","volume":"42","author":"Drouhet","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2006.04.006_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0190-9622(09)80305-8","article-title":"Mechanisms of action of systemic antifungal agents","volume":"28","author":"Elewski","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib14","unstructured":"ERTACZO\u00ae prescribing information. Skillman, NJ:OrthoNeutrogena, 2003."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib15","first-page":"752","article-title":"Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration","volume":"42","author":"Farr\u00e9","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0733-8635(05)70331-4","article-title":"Yeast infections","volume":"14","author":"Hay","year":"1996","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib17","series-title":"Vital and health statistics: series 11, No. 212. DHEW publication no. (PHS) 79\u20131660","article-title":"Skin conditions and related need for medical care among persons aged 1\u201374 years, United States, 1971\u201374","author":"Johnson","year":"1978"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/AAC.47.1.82-86.2003","article-title":"Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine","volume":"47","author":"Mukherjee","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib21","series-title":"Proceedings of Sertaconazole International Symposium. La Toja, Spain, 11\u201313 October 2002","first-page":"25","article-title":"Sertaconazole: a clinical update","author":"Palac\u00edn","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib19","first-page":"699","article-title":"In vitro activity of sertaconazole","volume":"42","author":"Palac\u00edn","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib20","first-page":"711","article-title":"In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans","volume":"42","author":"Palac\u00edn","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib22","first-page":"325","article-title":"In vitro antibacterial activity of sertaconazole","volume":"8","author":"Prats","year":"1995","journal-title":"Rev. Esp. Quimioterap."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib23","series-title":"ERTACZO\u2122 [sertaconazole nitrate] Cream, 2%","author":"Product Monograph","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib24","first-page":"691","article-title":"Synthesis and antimycotic activity of (benzo[b]thienyl)methyl ethers of 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol and of (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime","volume":"42","author":"Raga","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","article-title":"Antifungal susceptibility testing: practical aspects and current challenges","volume":"14","author":"Rex","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib26","unstructured":"Sertaconazole Product Monograph. Barcelona, Spain:Ferrer Grupo, 2004."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1590\/S1517-83822001000200012","article-title":"In vitro activity of antifungal and antiseptic agents against dermatophyte isolates from patients with tinea pedis","volume":"32","author":"Soares","year":"2001","journal-title":"Braz. J. Microb."},{"issue":"Suppl","key":"10.1016\/j.diagmicrobio.2006.04.006_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0020-7292(00)00349-0","article-title":"Sertaconazole in the treatment of mycoses: from dermatology to gynecology","volume":"71","author":"Torres","year":"2000","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib29","first-page":"757","article-title":"Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans","volume":"42","author":"Umbert","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.diagmicrobio.2006.04.006_bib30","series-title":"Proceedings of Sertaconazole International Symposium. La Toja, Spain, 11\u201313 October 2002","first-page":"29","article-title":"Sertaconazole: a clinical update","author":"Zsolt","year":"2002"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T02:26:57Z","timestamp":1547519217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0732889306001611"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.04.006","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}